from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3579c/-

LFCtreatmentdescriptionclass of inhibitor

-0.072

Amikacinug/mL Amikacintranslation

-1.378

Cap5-10ug/mL Capreomycintranslation

-1.615

Rox10-50 ug/mL Roxithromycintranslation

0.217

SM2-5 ug/mL Streptomycintranslation

0.283

Tet5-10 ug/mL Tetracyclinetranslation

1.099

Rif0.2-5ug/mL Rifampicintranscription

0.926

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.094

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.586

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.539

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.613

Clofazimine10-13 ug/mL Clofaziminerespiration

0.054

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.001

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.232

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.316

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.245

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.064

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.148

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.430

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.034

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.834

KCN5-20 ug/mL Potassium cyaniderespiration

-0.059

NaN30.2-2 mM Sodium aziderespiration

-0.771

Nigericin50 uM Nigericinrespiration

0.032

TRC10-150 ug/mL Triclosanrespiration

0.080

TRZ10-25 ug/mL Thioridazinerespiration

-0.548

Valinomycin0.5-10 uM Valinomycinrespiration

-1.248

ZnSO42 mM ZnSO4respiration

-0.068

menadione6-10 ug/mL Menadionerespiration

0.256

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.149

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.202

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.332

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.097

NRP_1Non-replicating persistence stage 1dosRassociated

0.379

Amp0.2mg/mL AmpicillincellWall

0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.135

Cerulenin0.32-5 ug/mL CerulenincellWall

0.941

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.365

EMB10-20 ug/mL EthambutolcellWall

0.135

Eta12-40 ug/mL EthionamidecellWall

0.186

INH0.2-0.4 ug/mL IsoniazidcellWall

0.483

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.437

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.652

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.074

BZA0.12 mg/mL BenzamidearomaticAmides

0.025

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.172

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.760

H2O24 mM hydrogen peroxideDNAdamaging

-0.204

Levo10 ug/mL LevofloxacinDNAdamaging

0.548

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.762

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.893

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.429

UVUV-irradiationDNAdamaging

0.520

ARP41-4 ug/mL Antitubercular compound ARP4?

0.473

Antimycin12.5-50 ug/mL Antimycin A?

-0.092

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.528

PA_110-50 ug/mL Antitubercular compound PA-1?

0.408

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.387

PA8240.2-2 ug/mL PA-824?

-1.053

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.255

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.366

Verapamil50 uM Verapamil?

-0.361

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.517

methoxatin10-20 ug/mL Methoxatin?